Skip to main content
. 2021 Apr 28;9:666453. doi: 10.3389/fpubh.2021.666453

Table 3.

Approximate costs related to the development of MDs (EUR).

Inactive Active Active/implants Comments
I I IIa IIb III
Time of development [year] 1 1 2 2 2
Employees HW 0 17,771 35,542 35,542 35,542 With a salary of 1,500EUR per month
SW 0 17,771 35,542 35,542 35,542 With a salary of 1,500EUR per month
other 35542 17,771 71,085 71,085 71,085 With a salary of 1,500EUR per month
Sterilization validation 0 0 1,851 1,851 1,851
Measurement validation 0 1,851 1,851 1,851 1,851
Tests el. Security 0 3,702 5,553 5,553 5,553 Not for implantable ones (joints, for stimulators)
EMC 0 1,851 3,702 3,702 3,702 EMC is not implantable (joints, it is a stimulator), but again they have a higher price for biological evaluation
Biological evaluation 1,851 1,851 5,553 5,553 5,553 Based on type of MD
Clinical evaluation 740 740 1,851 3,702 3,702 If the clinical trial is based on a clinical trial, even millions
Type test 740 740 3702 5,553 5,553
CE Conformity Declaration 0 0 7,405 9,256 11,107 Abroad: notified body: it is IIa - 20 thousand €; IIb - 25 thousand €, III - 30 thousand €, plus supervision every year about 5 thousand €. According to the MDR, it is expected that it should be up to 25% more.
QMS 5,553 5,553 5,553 5,553 5,553
PMCF After placing a product on the market, the cost depends on the type of product, its use and the complexity of the study itself
(large price range); estimate for IIb is part of the Appendix.
Total 44,428 69,604 17,9193 184,746 186,598